The Level of Antibodies to Tumor-Associated Glycans in Gastric Cancer Patients Is Lower than in Healthy Donors and Reduces with Age. [PDF]
Nikulin MP +16 more
europepmc +1 more source
We analyzed alterations of PAR metabolism‐related proteins in PARG inhibitor‐resistant HCT116RPDD cells. Although PARG levels remained unchanged, HCT116RPDD cells exhibited reduced PARP1 and ARH3 expression and elevated PAR levels. Interestingly, HCT116RPDD cells exhibited slightly elevated intracellular NAD+/NADH and ATP levels. Our findings suggest a
Kaede Tsuda, Yoko Ogino, Akira Sato
wiley +1 more source
Pulmonary Embolism in Antiphospholipid Syndrome (APS)-Where Are We and Where Are We Going? [PDF]
Lucki M +4 more
europepmc +1 more source
Chemoresistance in bladder cancer: Macrophage recruitment associated with CXCL1, CXCL5 and CXCL8 expression is characteristic of Gemcitabine/Cisplatin (Gem/Cis) Non‐Responder tumors (right side) while Responder tumors did not show substantial tumor‐stromal crosstalk (left side). All biological icons are attributed to Bioicons: carcinoma, cancerous‐cell‐
Sophie Leypold +11 more
wiley +1 more source
IgE Anti-Beta Coronaviruses Serology in Napoleon Soldiers, France. [PDF]
Merrouche NEH +6 more
europepmc +1 more source
A novel surface plasmon resonance approach to assess anti-dsDNA antibody kinetics and disease severity in systemic lupus erythematosus. [PDF]
Nagant C +6 more
europepmc +1 more source
Autoantibodies as Precision Tools in Connective Tissue Diseases: From Epiphenomenon to Endophenotype. [PDF]
Soyfoo M, Sarrand J.
europepmc +1 more source
Isohemagglutinins exhibit synergistic polyreactivity toward Streptococcus pneumoniae surface antigens: implications for broad-spectrum reactivity of human antibodies. [PDF]
Bernth Jensen JM +7 more
europepmc +1 more source
Anti-Idiotypic Antibodies in Immune Regulation and Disease: Therapeutic Promise for Next-Generation Vaccines. [PDF]
Timofeeva AM, Sedykh SE, Nevinsky GA.
europepmc +1 more source
Comparative Analysis of Glycan Composition in Therapeutic Antibodies via Glycan Profiling and Intact Mass Analysis. [PDF]
Chun YS +5 more
europepmc +1 more source

